These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6489539)

  • 1. Consequences of intrauterine contraception in diabetic women.
    Skouby SO; Mølsted-Pedersen L; Kosonen A
    Fertil Steril; 1984 Oct; 42(4):568-72. PubMed ID: 6489539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraception in diabetic women.
    Skouby SO; Mølsted-Pedersen L; Kühl C
    Acta Endocrinol Suppl (Copenh); 1986; 277():125-9. PubMed ID: 3532663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine contraceptive devices in diabetic women.
    Gosden C; Steel J; Ross A; Springbett A
    Lancet; 1982 Mar; 1(8271):530-5. PubMed ID: 6120391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of IUDs in developing countries: a comparative study.
    Farr G; Burdan A
    Netw Res Triangle Park N C; 1991 Sep; 12(2):6-8, 12. PubMed ID: 12284280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of the copper-releasing intrauterine contraceptive device and its significance.
    Chantler EN; Scott K; Filho CI; Elstein M; Faragher EB; Lorimer GW; Brough I
    Br J Obstet Gynaecol; 1984 Feb; 91(2):172-81. PubMed ID: 6696861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
    Elhag KM; Bahar AM; Mubarak AA
    J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of intrauterine contraceptive devices in diabetics.
    Craig GM
    Br J Sex Med; 1982 Feb; 9():44-8. PubMed ID: 12279278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD].
    Elia D; Belaisch J
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [For and against the IUD in diabetics].
    Serfaty D
    Contracept Fertil Sex (Paris); 1983 Dec; 11(12):1295-8. PubMed ID: 12312724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical study of the TCu-380 A and the TCu-200 B. IUDs.
    Kandil OF; El-sheikha Z; Hamza A
    Popul Sci; 1991 Jan; 10():35-40. PubMed ID: 12284660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness, safety, and acceptability of a copper intrauterine device (CU Safe 300) in type I diabetic women.
    Kimmerle R; Weiss R; Berger M; Kurz KH
    Diabetes Care; 1993 Sep; 16(9):1227-30. PubMed ID: 8404424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine device developments.
    Netw Res Triangle Park N C; 1984; 5(4):4-6. PubMed ID: 12313225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational diabetes in the past: a relative contraindication for intrauterine contraception.
    Blum M
    Adv Contracept Deliv Syst; 1985; (1):131-2. PubMed ID: 12267109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies on Cu-7; copper-IUD.
    Matsumoto S
    Nihon Funin Gakkai Zasshi; 1976 Jul; 21(3):70-82. PubMed ID: 12158549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrosion of filamentous intra-uterine copper. The MLCu250 and the MLCu375.
    Kosonen A; Thiery M
    Contraception; 1983 Jan; 27(1):85-93. PubMed ID: 6839762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.